Hong Kong Stock Market Anomaly | Fuhong Hanlin (02696.HK) surges over 8% in the afternoon to hit a new high Recently, the company introduced the innovative HER2 ADC in phase III clinical trial by QuintilesIMS.

According to Wisdom Financial APP, Fuhong Hanlin (02696.HK) surged over 8% in the afternoon, hitting a new high of 85.95 Hong Kong dollars. As of the time of writing, it has risen by 6.14%, to 83.85 Hong Kong dollars, with a trading volume of 95.14 million Hong Kong dollars.